DGCI

Dr Reddy’s Gets DCGI Nod for Single-Shot Sputnik Light Vaccine

Serum Institute, Bharat Biotech Vaccine Candidates Emergency Okay Paused

Initial Findings on ‘Adverse Event’ Didn’t Necessitate Halting of Vaccine Trials, Says Centre

The panel had also suggested that the company pay compensation of around Rs 20 lakh to the affected patients.. Credit: Reuters/File Photo

J&J Can Sell TB Drug to Minors After Govt Panel Waives Local Trials

Biocon Secures Approval to Use Drug on Coronavirus Patients

How the Indian Government Helped Let GVK Biosciences Off the Hook

There’s No Romance in this Story of Fudged Clinical Trials